Vnitr Lek 2013, 59(1):16-22
Outcomes of Catheter Ablation of Atrial Fibrillation in Patients over 65 Years of Age
- 1 Oddělení kardiologie Nemocnice Podlesí, a.s., Třinec, přednosta prim. MUDr. Marian Branny
- 2 Interní kardiologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Jindřich Špinar, CSc., FESC
Purpose:
This study assessed ablation techniques, recurrent arrhythmias, long-term outcomes, and complications of catheter ablation for atrial fibrillation (AF) in patients ≥ 65 years of age.
Methods:
Consecutive patients aged < 65 years (n = 653) vs ≥ 65 years (n = 213), who underwent catheter ablation of AF in the course of eight years, were compared. Ablation strategy and procedure endpoints were left at the operator's discretion.
Results:
The group of patients ≥ 65 years comprised more females (p < 0.001), and more frequently presented with persistent AF (p = 0.010). These patients less frequently underwent simple pulmonary vein isolation (p = 0.017); on the contrary, extensive ablation including coronary sinus intervention was more common (p = 0.020). There was no difference in repeat ablation procedures (25 % vs 26 % patients; p = 0.823, or 1.4 vs 1.5 ablation procedures/1 patients; p = 0.479, respectively). Spectrum of recurrent arrhythmias did not differ between the groups except for more frequent paroxysmal AF before the first repeat ablation in patients < 65 years (p = 0.050). At the end of 49 ± 26 month total follow-up, stable sinus rhythm (SR) was achieved in 85 % patients < 65 years vs 76 % patients ≥ 65 years (p = 0.318). To maintain stable SR, older patients more often continued to take antiarrhythmic medication (p = 0.054). More serious complication occurred in 3.8 % of the patients ≥ 65 years vs 2.1 % of the patients < 65 years of age (p = 0.207).
Conclusion:
Patients ≥ 65 years of age achieved insignificantly worse long-term outcome after insignificantly fewer repeat ablation procedures, and with more frequent use of antiarrhythmic drugs. SR maintenance and risk of complications were, however, favorable.
Keywords: atrial fibrillation; catheter ablation; age; outcomes
Received: September 7, 2012; Accepted: November 22, 2012; Published: January 1, 2013 Show citation
References
- Pappone C, Rosanio S, Augello G et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 2003; 42: 185-197.
Go to original source...
Go to PubMed...
- Wazni OM, Marrouche NF, Martin DO et al. Radiofrequency ablation vs. Antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005; 293: 2634-2640.
Go to original source...
Go to PubMed...
- Jais P, Cauchemez B et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 2008; 118: 2498-2505.
Go to original source...
Go to PubMed...
- Wokhlu A, Monahan KH, Hodge DO et al. Long-term quality of life after ablation of atrial fibrillation: the impact of recurrence symptom relief, and placebo effect. J Am Coll Cardiol 2010; 55: 2309-2316.
Go to original source...
Go to PubMed...
- Pappone C, Vicedomini G, Augello G et al. Radiofrequency catheter ablation and antiarrhythmic drug therapy: A prospective, randomized, 4-year follow-up trial: The APAF Study. Circ Arrhythm Electrophysiol 2011; 4: 808-814.
Go to original source...
Go to PubMed...
- Bulková V, Fiala M, Haman L et al. Zlepšení kvality života po ablaci dlouhodobě perzistentní versus paroxysmální fibrilace síní: výsledky dvouletého sledování. Vnitř Lék 2011; 57: 456-462.
Go to PubMed...
- Berruezo A, Tamborero D, Mont L et al. Pre-procedural predictors of atrial fibrillation recurrence after circumferntial pulmonary vein ablation. Eur Heart J 2007; 28: 836-841.
Go to original source...
Go to PubMed...
- Tzou WS, Marchlinski FE, Zado ES et al. Long-term outcome after successful catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3: 237-242.
Go to original source...
Go to PubMed...
- The Atrial Fibrillation Follow up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-1833.
Go to original source...
Go to PubMed...
- The AFFIRM Investigators. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Circulation 2004; 109: 1509-1513.
Go to original source...
Go to PubMed...
- Fiala M, Chovančík J, Heinc P et al. Léčba symptomatické intermitentní fibrilace síní katetrovou ablací v levé srdeční síni: bezprostřední a dlouhodobé výsledky u 150 pacientů. Vnitř Lék 2005; 51: 971-983.
- Fiala M, Chovančík J, Nevřalová R et al. Pulmonary vein isolation using segmental versus electroanatomical circumferential ablation for paroxysmal atrial fibrillation: over 3-year results of a prospective randomized study. J Interv Card Electrophysiol 2008; 22: 13-21.
Go to original source...
Go to PubMed...
- Fiala M, Chovančík J, Nevřalová R et al. Termination of long-lasting persistent versus short-lasting persistent and paroxysmal atrial fibrillation by ablation. Pacing Clin Electrophysiol 2008; 31: 985-997.
Go to original source...
Go to PubMed...
- Cappato R, Calkins H, Chen SA et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3: 32-38.
Go to original source...
Go to PubMed...
- Fiala M, Chovančík J, Wojnarová D et al. Results of complex left atrial ablation of long-lasting persistent atrial fibrillation. J Interv Card Electrophysiol 2008; 23: 189-198.
Go to original source...
Go to PubMed...
- Bunch TJ, Weiss JP, Crandall BG et al. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in octogenarians. Pacing Clin Electrophysiol 2010; 33: 146-152.
Go to original source...
Go to PubMed...